-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
-
Summary
-
Alnylam Pharmaceuticals, Inc. quarterly/annual Return On Assets history and growth rate from 2011 to 2023.
- Alnylam Pharmaceuticals, Inc. Return On Assets for the quarter ending June 30, 2024 was -1.88 %, a 93.9% increase year-over-year.
- Alnylam Pharmaceuticals, Inc. annual Return On Assets for 2023 was -12.2 %, a 62.7% increase from 2022.
- Alnylam Pharmaceuticals, Inc. annual Return On Assets for 2022 was -32.7 %, a 33% decline from 2021.
- Alnylam Pharmaceuticals, Inc. annual Return On Assets for 2021 was -24.6 %, a 11.5% increase from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)